Applying dried blood spot sampling with LCMS quantification in the clinical development phase of tasquinimod.

Svensson, Leif D
Sennbro, Carl Johan
Svanström, Camilla
Hansson, Gunnar P

Open link

Publication date

January 2015

DOI

10.4155/bio.14.259

Publisher

Future Science Ltd

ISSN

1757-6180

Citation count (estimate)

Abstract

Tasquinimod is an orally active anticancer drug in late clinical development. Here we describe the development and validation of a bioanalytical method based upon dried blood spot analysis in combination with LCMS/MS and stable isotope dilution

Extracted data

We use cookies to provide a better user experience.

Data Protection

Applying dried blood spot sampling with LCMS quantification in the clinical development phase of tasquinimod.

Abstract

Extracted data

Applying dried blood spot sampling with LCMS quantification in the clinical development phase of tasquinimod.

Abstract

Extracted data

Related items

Related items